Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
MORNING UPDATE: Man Securities Issues Alerts for AMAT, BGEN, SCMR, VXGN, And CERN CHICAGO, Nov. 13 /PRNewswire/ -- Man Securities issues the following Morning Update at 8:30 AM EST with new...
Biogen und IDEC Pharmaceuticals schliessen Fusion zur Schaffung neuen f?hrenden Biotechnologieunternehmens ab CAMBRIDGE, Massachusetts, und SAN DIEGO, November 13 /PRNewswire/ -- Die IDEC...
Biogen e IDEC Pharmaceuticals completan su fusi?n y crean un nuevo l?der biotecnol?gico CAMBRIDGE, Massachusetts, November 13 /PRNewswire/ -- IDEC Pharmaceuticals Corporation y Biogen Inc. han...
Biogen et IDEC Pharmaceuticals ont conclu une fusion qui donne naissance ? un nouveau chef de file de l'industrie biotechnologique CAMBRIDGE, Massachusetts et SAN DIEGO, November 13 /PRNewswire/...
Biogen and IDEC Pharmaceuticals Complete Merger to Create New Biotechnology Industry Leader CAMBRIDGE, Massachusetts and SAN DIEGO, November 13 /PRNewswire/ -- IDEC Pharmaceuticals Corporation and...
Biogen and IDEC Pharmaceuticals Complete Merger to Create New Biotechnology Industry Leader CAMBRIDGE, Mass., and SAN DIEGO, Nov. 12 /PRNewswire-FirstCall/ -- IDEC Pharmaceuticals Corporation...
Biogen and IDEC Pharmaceuticals to Make Presentation at Credit Suisse First Boston Healthcare Conference CAMBRIDGE, Mass., and SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Biogen, Inc. and IDEC...
Biogen anuncia los resultados de los ensayos de fase II con ADENTRI CAMBRIDGE, Massachusetts, November 10 /PRNewswire/ -- Biogen (Nasdaq: BGEN) ha anunciado hoy los resultados positivos de...
Biogen Announces Results of Phase II Trials With ADENTRI at American Heart Association Meeting CAMBRIDGE, Mass., November 10 /PRNewswire/ -- Biogen (Nasdaq: BGEN) today announced positive results...
Biogen Announces Results of Phase II Trials With ADENTRI(TM) at American Heart Association Meeting CAMBRIDGE, Mass., Nov. 10 /PRNewswire-FirstCall/ -- Biogen today announced positive results of...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
